Press Releases from DelveInsight (513 total)
Lung Adenocarcinoma Clinical Trials Analysis 2025: Targeted Therapies, Immunothe …
DelveInsight's "Lung Adenocarcinoma - Clinical Trials Analysis, 2025" describes a dynamic and fast-moving development landscape focusing on two complementary goals: (1) inhibit tumor growth and…
Neurofibromatosis Type 1 Clinical Trials Analysis 2025: Targeted RAS-Pathway and …
The Neurofibromatosis Type 1 (NF1) clinical trial landscape in 2025 focuses on two main goals: controlling plexiform and cutaneous neurofibromas and preventing malignant peripheral nerve…
Neisseria Meningitidis Meningitis Clinical Trials Analysis 2025: Multivalent Vac …
DelveInsight's "Neisseria Meningitidis Meningitis - Clinical Trials Analysis, 2025" outlines a rapidly evolving landscape aimed at two primary goals: (1) provide broad serogroup coverage through…
Essential Tremor Clinical Trials Analysis 2025: Novel Pharmacologics, Neuromodul …
DelveInsight's "Essential Tremor - Clinical Trials Analysis, 2025" highlights a dynamic development landscape focused on two complementary goals: (1) reduce tremor severity and improve motor…
Liver Fibrosis Clinical Trials Analysis 2025: Antifibrotic Agents, Gene Modulato …
DelveInsight's "Liver Fibrosis - Clinical Trials Analysis, 2025" outlines a rapidly evolving development landscape with two main objectives: (1) halt or reverse hepatic fibrosis progression,…
Cataract Clinical Trials Analysis 2025: Topical Small Molecules, Regenerative Th …
DelveInsight's "Cataract - Clinical Trials Analysis, 2025" highlights a shifting development landscape aiming to complement or reduce reliance on surgery through pharmacologic, regenerative, and device-based…
Diabetic Gastroparesis Clinical Trials Analysis 2025: Prokinetic Agents, Ghrelin …
DelveInsight's "Diabetic Gastroparesis - Clinical Trials Analysis, 2025" outlines a dynamic research landscape addressing the chronic, debilitating delays in gastric emptying associated with diabetes.
Current trials…
Ataxia Clinical Trials Analysis 2025: Gene Therapies, Ion Channel Modulators, an …
DelveInsight's "Ataxia - Clinical Trials Analysis, 2025" highlights a rapidly evolving pipeline targeting the genetic and neurodegenerative roots of ataxia.
Ongoing phase II-III studies explore gene…
Bacteremia Clinical Trials Analysis 2025: Novel Antibiotics, Monoclonal Antibodi …
DelveInsight's "Bacteremia - Clinical Trials Analysis, 2025" highlights an active development landscape aimed at rapidly eliminating bloodstream infections and preventing progression to sepsis.
Ongoing trials evaluate…
Biliary Tumor Clinical Trials Analysis 2025: Targeted Therapies, Immuno-Oncology …
DelveInsight's "Biliary Tumors - Clinical Trials Analysis, 2025" highlights a rapidly evolving development landscape focused on both intrahepatic and extrahepatic cholangiocarcinomas.
Current trials evaluate FGFR and…
Lewy Body Disease Clinical Trials Analysis 2025: α-synuclein Immunotherapies, N …
DelveInsight's "Lewy Body Disease - Clinical Trials Analysis, 2025" highlights a rapidly evolving trial landscape targeting the underlying biology and complex symptomatology of dementia with…
Chronic Pulmonary Infections Clinical Trials Analysis 2025: Inhaled Antimicrobia …
DelveInsight's "Chronic Pulmonary Infections - Clinical Trials Analysis, 2025" outlines an active and heterogeneous development landscape addressing long-standing airway infections (non-CF bronchiectasis, chronic Pseudomonas infection,…
Chronic Pulmonary Infections Clinical Trials Analysis 2025: Inhaled Antimicrobia …
DelveInsight's "Chronic Pulmonary Infections - Clinical Trials Analysis, 2025" outlines an active and heterogeneous development landscape addressing long-standing airway infections (non-CF bronchiectasis, chronic Pseudomonas infection,…
ATTR Amyloidosis Clinical Trials Analysis 2025: RNA-silencing, TTR Stabilizers, …
DelveInsight's "ATTR Amyloidosis - Clinical Trials Analysis, 2025" describes a crowded, fast-moving development landscape focused on two complementary goals: (1) suppress hepatic TTR production or…
Alcohol Use Disorder Clinical Trials Analysis 2025: Psychedelic-Assisted Therapy …
DelveInsight's "Alcohol Use Disorder - Clinical Trials Analysis, 2025" describes a broad, rapidly evolving trial landscape that pairs novel pharmacology with behavioral interventions to reduce…
Heart Failure Clinical Trials Analysis 2025: SGLT2 Inhibitors, Novel Inotropes, …
DelveInsight's "Heart Failure - Clinical Trials Analysis, 2025" outlines a dynamic development landscape targeting the multifactorial pathophysiology of heart failure (HF), including myocardial dysfunction, fluid…
Bipolar Disorder Clinical Trials Analysis 2025 Novel Mechanisms and Digital Ther …
DelveInsight's "Bipolar Disorder - Clinical Trials Analysis, 2025" reviews a dynamic pipeline aiming to address the unmet needs of patients struggling with recurring episodes of…
Celiac Disease Clinical Trials Analysis 2025 Novel Immunotherapies and Gut-Targe …
DelveInsight's "Celiac Disease - Clinical Trials Analysis, 2025" highlights a rapidly progressing pipeline addressing the limitations of the gluten-free diet, the only current standard of…
Coronary Artery Disease Clinical Trials Analysis 2025: Novel Antithrombotics, Re …
DelveInsight's "Coronary Artery Disease (CAD) - Clinical Trials Analysis, 2025" explores a diverse pipeline targeting the world's leading cause of morbidity and mortality. Despite the…
Anthrax Clinical Trials Analysis 2025: Next-Generation Vaccines, Monoclonal Anti …
DelveInsight's "Anthrax - Clinical Trials Analysis, 2025" reviews an evolving pipeline designed to strengthen protection against Bacillus anthracis infection and biothreat exposure. While antibiotics remain…
Candidiasis Clinical Trials Analysis 2025: Oral Agents, Next-Generation Echinoca …
DelveInsight's "Candidiasis - Clinical Trials Analysis, 2025" examines an active clinical landscape addressing both mucosal (vulvovaginal) and invasive candidiasis. Unmet needs for safe, oral, and…
Necrotizing Enterocolitis Clinical Trials Analysis 2025: Probiotics, HMOs, and R …
DelveInsight's "Necrotizing Enterocolitis (NEC) - Clinical Trials Analysis, 2025" highlights an evolving pipeline aimed at reducing NEC incidence and severity in preterm infants. With NEC…
Brain Hemorrhage Clinical Trials Analysis 2025: Hemostasis, Neuroprotection, and …
DelveInsight's "Brain Hemorrhage - Clinical Trials Analysis, 2025" surveys an active acute-care landscape focused on reducing hematoma expansion, limiting secondary injury, and improving functional recovery…
Cachexia Clinical Trials Analysis 2025: Metabolic Modulators, Anabolic Therapies …
DelveInsight's "Cachexia - Clinical Trials Analysis, 2025" examines a diverse development landscape targeting the complex metabolic, inflammatory, and neurohormonal drivers of cancer- and disease-related wasting.…
Cystitis Clinical Trials Analysis 2025: Novel Antimicrobials, Non-antibiotic Pre …
DelveInsight's "Cystitis - Clinical Trials Analysis, 2025" reviews an active pipeline addressing both uncomplicated and complicated urinary tract infections (UTIs)/cystitis, with emphasis on recurrent cystitis…
Nasopharyngeal Cancer Clinical Trials Analysis 2025: Immunotherapies, Targeted A …
DelveInsight's "Nasopharyngeal Cancer (NPC) - Clinical Trials Analysis, 2025" explores an evolving pipeline focused on improving outcomes for patients with advanced or recurrent disease. Despite…
Hereditary Angioedema Clinical Trials Analysis 2025: Novel Therapeutics, Prophyl …
DelveInsight's "Hereditary Angioedema (HAE) - Clinical Trials Analysis, 2025" reviews a rapidly evolving clinical pipeline designed to prevent and manage acute HAE attacks. Despite available…
Cutaneous Lupus Erythematosus Clinical Trials Analysis 2025: Targeted Immunomodu …
DelveInsight's "Cutaneous Lupus Erythematosus (CLE) - Clinical Trials Analysis, 2025" highlights a dynamic pipeline addressing persistent gaps in treatment for patients with lupus-specific skin manifestations.…
Febrile Neutropenia Clinical Trials Analysis 2025: Antimicrobial Stewardship, No …
DelveInsight's "Febrile Neutropenia - Clinical Trials Analysis, 2025" reviews an evolving pipeline focused on reducing infection-related complications in cancer patients undergoing chemotherapy. Despite advances in…
Vasculitis Clinical Trials Analysis 2025: Targeted Immunotherapies, Complement I …
DelveInsight's "Vasculitis - Clinical Trials Analysis, 2025" highlights a dynamic pipeline aimed at improving remission durability and minimizing steroid dependence in this group of rare,…
Advanced Gastric Carcinoma Clinical Trials Analysis 2025: Targeted Agents, Immun …
DelveInsight's "Advanced Gastric Carcinoma (AGC) - Clinical Trials Analysis, 2025" reviews a rapidly evolving clinical pipeline focused on enhancing overall survival, response durability, and tolerability…
Advanced Urothelial Carcinoma Clinical Trials Analysis 2025: Targeted Therapies, …
DelveInsight's "Advanced Urothelial Carcinoma (aUC) - Clinical Trials Analysis, 2025" examines a dynamic pipeline focused on improving survival, response rates, and tolerability for patients with…
Post-Polycythemia Vera Myelofibrosis Clinical Trials Analysis 2025: Novel JAK In …
DelveInsight's "Post-Polycythemia Vera Myelofibrosis (PPV-MF) - Clinical Trials Analysis, 2025" highlights an evolving pipeline designed to tackle the limitations of current therapies and improve long-term…
Immunologic Deficiency Syndrome Clinical Trials Analysis 2025: Gene Therapies, N …
DelveInsight's "Immunologic Deficiency Syndrome - Clinical Trials Analysis, 2025" reviews the rapidly evolving clinical landscape for primary and selected secondary immunodeficiency disorders, a heterogeneous group…
Vestibular Schwannoma Clinical Trials Analysis 2025: Hearing-Preservation Strate …
DelveInsight's "Vestibular Schwannoma - Clinical Trials Analysis, 2025" examines the evolving clinical-trial landscape for vestibular schwannoma (VS). This typically benign cranial nerve tumor can cause…
Diabetic Foot Ulcers Pipeline Insight 2025: 25+ Regenerative, Antimicrobial, and …
DelveInsight's "Diabetic Foot Ulcers - Pipeline Insight, 2025" survey examines more than 25 therapies in development that address diabetic foot ulcers (DFUs), a leading cause…
Attention Deficit Hyperactivity Disorder Clinical Trials Analysis 2025: Novel Me …
DelveInsight's "Attention Deficit Hyperactivity Disorder (ADHD) - Clinical Trials Analysis, 2025" reviews an evolving pipeline focused on enhancing symptom control, reducing side effects, and improving…
Motor Neuron Disease Pipeline Insight 2025: Gene-Targeted Therapies, Neuroprotec …
DelveInsight's "Motor Neuron Disease - Pipeline Insight, 2025" highlights 200+ therapies in development for ALS and related motor neuron disorders. Despite supportive care being the…
Herpes Labialis Clinical Pipeline Insight 2025: Antivirals, Vaccines, and Long-A …
DelveInsight's "Herpes Labialis - Clinical Pipeline Insight, 2025" reviews more than 6+ therapies in development for herpes labialis (cold sores), a recurrent infection most commonly…
Microbiome Disease Pipeline Insight 2025: 180+ Pipeline Drugs, Live Biotherapeut …
DelveInsight's "Microbiome Disease - Pipeline Insight, 2025" covers over 180+ therapies in development targeting microbiome-associated diseases across diverse therapeutic areas, including gastrointestinal, metabolic, dermatological, neurological,…
Renal Cancer Clinical Trials Analysis 2025: Next-Generation Targeted Therapies a …
DelveInsight's "Renal Cancer - Clinical Trials Analysis, 2025" explores the rapidly evolving therapeutic landscape for renal cell carcinoma (RCC), the most common form of kidney…
Polymyositis Clinical Trial Analysis 2025: How Emerging Therapies Are Shaping th …
DelveInsight's "Polymyositis - Pipeline Insight, 2025" examines the evolving therapeutic landscape for polymyositis, a rare autoimmune inflammatory myopathy characterized by progressive muscle weakness and systemic…
Ulcerative Colitis Clinical Trials Analysis 2025: Advancing Biologics, Small Mol …
DelveInsight's "Ulcerative Colitis - Clinical Trials Analysis, 2025" reviews the expanding landscape of therapies in development for ulcerative colitis (UC), a chronic inflammatory bowel disease…
Amyloid Light-Chain Amyloidosis Clinical Trials Analysis 2025: Emerging Therapie …
DelveInsight's "Amyloid Light-Chain (AL) Amyloidosis - Clinical Trials Analysis, 2025" examines the evolving therapeutic landscape for Amyloid Light-Chain Amyloidosis, a rare and life-threatening disorder characterized…
Psoriatic Arthritis Clinical Trials Analysis 2025: Expanding Biologics, Small Mo …
DelveInsight's "Psoriatic Arthritis - Clinical Trials Analysis, 2025" highlights the dynamic evolution of the therapeutic landscape for psoriatic arthritis (PsA), a chronic immune-mediated inflammatory arthritis…
Ischemic Stroke Clinical Trials 2025: Tenecteplase FDA Approval, Thrombectomy Up …
DelveInsight's "Ischemic Stroke - Clinical Trials, 2025" captures a rapidly evolving landscape in which improvements in acute reperfusion (thrombolysis and endovascular thrombectomy), adjunctive neuroprotection, and…
Attention Deficit Hyperactivity Disorder Clinical Trials 2025: 22+ Pipeline Ther …
DelveInsight's "Attention Deficit Hyperactivity Disorder - Clinical Trials, 2025" reviews over 22 therapies in development for ADHD, a highly prevalent neurodevelopmental disorder affecting both children…
Chronic Heart Failure Clinical Trials 2025: 25+ Pipeline Therapies, SGLT2 Inhibi …
DelveInsight's "Chronic Heart Failure - Clinical Trials, 2025" highlights 25+ therapies in development for CHF, a progressive condition marked by high morbidity and mortality. Beyond…
Beta-Thalassemia Clinical Trials 2025: 22+ Pipeline Therapies, Gene Editing, and …
DelveInsight's "Beta-Thalassemia - Clinical Trials, 2025" reviews over 22 therapies in development for beta-thalassemia, a rare inherited blood disorder characterized by impaired hemoglobin production and…
Atopic Dermatitis Clinical Trials 2025: Incyte Announces Additional FDA Approval …
DelveInsight's "Atopic Dermatitis - Clinical Trials, 2025" reviews 90+ therapies currently in development for atopic dermatitis, a chronic inflammatory skin condition that imposes a high…
